Related Experiment Videos
Small PMMA beads improve gentamicin release
1Department of Orthopedics, Academic Hospital Maastricht, The Netherlands.
Abstract:
The in vivo release of gentamicin base from conventional polymethyl methacrylate 7-mm beads was compared with that from the recently introduced 3 x 5-mm minibeads. The release in 14 days from minibeads was 93 percent of their gentamicin content, while the large beads released an average of 24 percent. The volume of the minibeads is one fifth of that of the large beads. Owing to the improved release combined with the smaller size, total release from minibeads in a cavity may be some seven times that from large beads. When in smaller cavities a strong bactericidal effect is desired, minibeads are to be preferred to large beads.
Insights
Gentamicin minibeads release significantly more antibiotic over 14 days compared to larger beads. Their smaller size and improved release make them ideal for achieving a strong bactericidal effect in smaller bone cavities.
Area of Science:
- Biomaterials science
- Infectious disease research
- Drug delivery systems
Background:
- Polymethyl methacrylate (PMMA) beads are used for localized gentamicin delivery.
- Conventional 7-mm PMMA beads have limitations in drug release efficiency.
- Recently developed 3 x 5-mm minibeads offer a potential alternative.
Purpose of the Study:
- To compare the in vivo gentamicin base release from conventional 7-mm PMMA beads and new 3 x 5-mm minibeads.
- To evaluate the efficacy of minibeads for achieving bactericidal effects in bone cavities.
Main Methods:
- In vivo study comparing drug release profiles.
- Measurement of gentamicin release over a 14-day period.
- Comparison of bead volumes and total drug release.
Main Results:
- Minibeads released 93% of gentamicin content in 14 days, compared to 24% from large beads.
- Minibead volume is one-fifth that of large beads.
- Total gentamicin release from minibeads may be seven times greater than from large beads.
Conclusions:
- Gentamicin minibeads demonstrate superior in vivo release kinetics compared to conventional large beads.
- The combination of smaller size and enhanced release makes minibeads advantageous for localized gentamicin delivery.
- Minibeads are recommended for achieving potent bactericidal effects in smaller bone cavities.